|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the creation, management, and administration of the |
|
Texas Pharmaceutical Initiative. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subtitle D, Title 10, Government Code, is |
|
amended by adding Chapter 2177 to read as follows: |
|
CHAPTER 2177. TEXAS PHARMACEUTICAL INITIATIVE |
|
Sec. 2177.001. DEFINITIONS. In this chapter: |
|
(1) "Initiative" means the Texas Pharmaceutical |
|
Initiative established in Sec. 2177.002. |
|
(2) "Board" means the governing board established in |
|
Sec. 2177.003. |
|
Sec. 2177.002. TEXAS PHARMACEUTICAL INITIATIVE; |
|
ESTABLISHMENT. The Texas Pharmaceutical Initiative is established |
|
to provide cost effective prescription drug access for employees, |
|
dependents, and retirees of public higher education systems and |
|
institutions, Employees Retirement System of Texas members, |
|
Teacher Retirement System of Texas members, persons confined by the |
|
Texas Department of Criminal Justice or the Texas Juvenile Justice |
|
Department, recipients of medical assistance, enrollees of the |
|
child health plan program, and other public, non-profit, and |
|
for-profit entities. |
|
Sec. 2177.003. GOVERNING BOARD. (a) The initiative shall |
|
be governed by a board that consists of: |
|
(1) the commissioner of the Texas Health and Human |
|
Services Commission, or their designee; |
|
(2) the executive director of the Employees Retirement |
|
System of Texas, or their designee; |
|
(3) the executive director of the Teacher Retirement |
|
System of Texas, or their designee; |
|
(4) three members appointed by the governor; |
|
(5) one member appointed by the governor from a list of |
|
three names submitted by the lieutenant governor; |
|
(6) one member appointed by the governor from a list of |
|
three names submitted by the speaker of the house of |
|
representatives; and |
|
(6) the chancellor of the University of Texas System, |
|
or the chancellor's designee, in an ex-officio capacity. |
|
(b) A vacancy on the board shall be filled in the same manner |
|
as the original appointment. |
|
(c) The board is administratively attached to the Health and |
|
Human Services Commission. |
|
(d) The governor shall select the presiding officer of the |
|
board. |
|
Sec. 2177.004. GENERAL DUTIES. (a) The board established |
|
under SECTION 2177.003 shall: |
|
(1) develop and implement the initiative and related |
|
programs established in this chapter; |
|
(2) establish procedures and policies for the |
|
administration of the board; |
|
(3) establish procedures to document compliance by |
|
board members and staff with applicable laws governing conflicts of |
|
interest; and |
|
(4) adopt all necessary rules to implement this |
|
chapter. |
|
(b) The board may: |
|
(1) execute all contracts and other documents, adopt |
|
all proceedings, and conduct all activities determined by the board |
|
to be necessary to carry out the purposes of this chapter. The |
|
board may authorize one or more members of the board to execute |
|
contracts and other documents on behalf of the board; and |
|
(2) establish and create any committees or other |
|
entities the board may deem necessary to exercise the powers |
|
provided in this act. The board may delegate to such committees or |
|
other entities administrative duties and other powers as the board |
|
may deem necessary; |
|
(3) hire a chief executive officer and employ |
|
necessary staff to provide administrative support; |
|
(4) make grants to provide funds to public or private |
|
persons to implement the Texas Pharmaceutical Initiative. |
|
(c) the board is required to implement a provision of this |
|
chapter only if the legislature appropriates money specifically for |
|
that purpose. If the legislature does not appropriate money |
|
specifically for that purpose, the board may, but is not required |
|
to, implement a provision of this chapter. |
|
Sec. 2177.005. TRANSPARENT PHARMACY BENEFIT MANAGER. (a) |
|
The board shall establish and implement a statewide transparent |
|
pharmacy benefit manager to provide cost-effective prescription |
|
drugs to entities and organizations served by the Initiative. |
|
(b) The pharmacy benefit manager shall provide pricing |
|
transparency, pass-through of all rebates and fees, and fair and |
|
equitable pricing to any pharmacy that chooses to participate in |
|
the pharmacy benefit manager's pharmacy network. |
|
(c) The pharmacy benefit manager shall contract with |
|
appropriate entities to: |
|
(1) provide evidence-based benefit design, prior |
|
authorization, and new drug review; and |
|
(2) partner with suppliers, pharmaceutical |
|
manufacturers, and group purchasing organizations for competitive |
|
drug acquisition. |
|
(d) The pharmacy benefit manager may charge fees for |
|
startup, enrollment, and ongoing management to support operational |
|
costs, program development, and expansion. |
|
Sec. 2177.006. CENTRAL SERVICE CENTER AND SATELLITE |
|
DISTRIBUTION FACILITIES. (a) The board shall establish and |
|
implement a central service center and associated network of |
|
satellite distribution facilities to provide pharmacy and medical |
|
supplies in support of Texas public higher education systems and |
|
institutions, the Employees Retirement System of Texas, the Teacher |
|
Retirement System of Texas, the Texas Department of Criminal |
|
Justice, the Texas Juvenile Justice Department, and other public, |
|
non-profit, and for-profit entities. The center shall: |
|
(1) be constructed to withstand severe weather, |
|
natural disasters, and power outages, and shall be capable of |
|
supporting disaster preparedness and relief statewide; and |
|
(2) include a mail order pharmacy and specialty |
|
pharmacy. |
|
(b) The center may assess a stock carrying charge, |
|
transaction fees, or other fees to support distribution and other |
|
operational costs, including overhead and margin. |
|
(c) The mail order and specialty pharmacy may receive |
|
payment for dispensing prescription drugs and may assess |
|
dispensing, delivery, and handling fees. |
|
Sec. 2177.007 PHARMACEUTICAL ADVANCED PREPARATION |
|
FACILITY. (a) The board shall establish a pharmaceutical advanced |
|
preparation facility to provide Food and Drug Administration |
|
approved 503B compounding, manufacturing, CAR-T and other gene |
|
therapies, precision medicine, and advanced labs for quality |
|
control, preparation and compounding in support of innovative |
|
therapeutics and drug research. |
|
(b) The facility shall be operated by a 501 c(3) established |
|
by the board. |
|
(c) The facility may charge fees for drug preparation, |
|
manufacturing, CAR-T, gene therapy, and 503B compounding to support |
|
operational costs, including overhead and margin. |
|
Sec. 2177.008 ADVANCED HEALTH CARE COST AND CLAIMS ANALYTIC |
|
SERVICES. (a) The board shall contract to provide advanced health |
|
care cost and claims analytic services to support the transparent |
|
pharmacy benefit manager, mail order and specialty pharmacies, |
|
central service center, and pharmaceutical advanced preparation |
|
facility established in this chapter, and to support population |
|
health and research. |
|
Sec. 2177.009 GENERIC DRUG MANUFACTURING FACILITY. (a) The |
|
board may enter into an agreement to establish a facility providing |
|
for the manufacturing of generic drugs. In entering into an |
|
agreement, the board shall prioritize savings and access to |
|
affordable medications. |
|
Sec. 2177.010 TEXAS PHARMACY INITIATIVE FUND. (a) The |
|
Texas Pharmaceutical Initiative Fund is created as a trust fund |
|
outside the treasury with the comptroller. The fund consists of |
|
money from: |
|
(1) gifts, grants, or donations to the executive |
|
committee; and |
|
(2) any other source appropriated or designated by the |
|
legislature. |
|
(b) The board may utilize the fund for the purpose of |
|
carrying out this chapter. |
|
(c) The board shall develop procedures for administration |
|
and approval of expenditures through the fund. |
|
Sec. 2177.011. GIFTS, GRANTS, AND DONATIONS. The board may |
|
accept on behalf of the initiative gifts, grants, or donations from |
|
any public or private source for the purpose of carrying out this |
|
chapter. |
|
Sec. 2177.012. ANNUAL REPORT. Not later than December 31 of |
|
each year, the board shall submit to the Texas Legislature a written |
|
report that outlines: |
|
(1) the activities and objectives of the initiative; |
|
(2) cost savings derived by state entities as a result |
|
of participation in the initiative; and |
|
(3) any legislative recommendations. |
|
SECTION 2. This Act takes effect immediately if it receives |
|
a vote of two-thirds of all the members elected to each house, as |
|
provided by SECTION 39, Article III, Texas Constitution. If this |
|
Act does not receive the vote necessary for immediate effect, this |
|
Act takes effect September 1, 2023. |